The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Gastroenterology
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1462122
This article is part of the Research Topic Diagnosis and Management of Acute, Chronic, and Autoimmune Pancreatitis View all 5 articles
The composition of the stent microbiome is associated with morbidity and adverse events during endoscopic drainage therapy of pancreatic necroses and pseudocysts
Provisionally accepted- 1 Universitätsmedizin Greifswald, Greifswald, Germany
- 2 Institute for Implant Technology and Biomaterials e. V., Rostock, Germany, Rostock, Germany
- 3 Institute for Biomedical Engineering, Rostock University Medical Center, Rostock, Germany, Rostock, Germany
- 4 University of Kiel, Kiel, Schleswig-Holstein, Germany
- 5 Department of Internal Medicine IV, Klinikum Südstadt Rostock, Rostock, Germany
- 6 LMU Munich University Hospital, Munich, Bavaria, Germany
Background: Development of pancreatic necroses or pseudocysts are typical complications of pancreatitis and may require endoscopic drainage therapy using metal or plastic stents. Microbial infection of these lesions poses a major challenge. So far, the composition and significance of the microbial colonization on drainage stents are largely unknown although it may impact outcomes during endoscopic drainage therapy. Methods: A total of 26 stents used for drainage of pancreatic lesions were retrieved and the stent microbiome was determined by 16S rRNA gene sequencing. Additional analysis included comparison of the stent microbiome to the intracavitary necrosis microbiome as well as scanning electron microscopy (SEM) and micro-computed tomography (µCT) imaging of selected metal or plastic stents. Results: The stent microbiome comprises a large proportion of opportunistic enteric pathogens such as Enterococcus (14.4%) or Escherichia (6.1%) as well as oral bacteria like Streptococcus (13.1%). Increased levels of opportunistic enteric pathogens were associated with a prolonged hospital stay (r=0.77, p=3e-06) and the occurrence of adverse events during drainage therapy (p=0.011). Higher levels of oral bacteria were associated (r=-0.62, p=8e-04) with shorter durations of inpatient treatment. SEM and µCT investigations revealed complex biofilm networks on the stent surface. Conclusion: The composition of the stent microbiome is associated with prolonged hospital stays and adverse events during endoscopic drainage therapy, highlighting the need for effective infection control to improve patient outcomes. In addition to systemic antibiotic therapy, antimicrobial stent coatings could be a conceivable option to influence the stent microbiome and possibly enhance control of the necrotic microflora.
Keywords: acute pancreatitis, pancreatic necrosis, necrosis microbiome, microbiota, LAMS, WON
Received: 09 Jul 2024; Accepted: 02 Sep 2024.
Copyright: © 2024 Frost, Khaimov, Senz, Weiss, Klußmann-Fricke, Rühlemann, Bang, Franke, Pickartz, Budde, Aghdassi, Siewert, Weiss, Grabow, Lerch and Sendler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fabian Frost, Universitätsmedizin Greifswald, Greifswald, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.